Originated by VidaPeps LLC, which attests it authorized this test as the brand of record.
Axiom confirmed this brand is a registered Axiom account. This does not confirm the product's origin, chain of custody, or that the brand authorized this specific test.
Molecular Mass Fingerprinting
Molecular mass fingerprinting confirms the primary component BPC-157 at [M+H]+ consistent with the neutral monoisotopic/average-MW target (theoretical average MW 1419.53 Da; observed 1419.02 Da, delta 0.51 Da, within the 1.0 Da tolerance). The WOLVERINE recovery blend comprises four peptides: BPC-157 (Body Protection Compound-157, C62H98N16O22), TB-500 (Thymosin Beta-4 fragment / Ac-LKKTETQ), GHK-Cu (Glycyl-L-Histidyl-L-Lysine copper complex), and KPV (Lys-Pro-Val, alpha-MSH C-terminal tripeptide). Each component was resolved chromatographically and its identity confirmed by ESI+ precursor/product ion transitions. Identity: PASS.
All analytical testing, validation reports, and interactive Certificates of Analysis (COAs) provided by Axiom Analytics are intended strictly for Research Use Only (RUO) in in-vitro or laboratory animal model environments. Axiom Analytics does not analyze, validate, evaluate, or make any representations regarding the safety, efficacy, toxicity, or legality of any tested substance for human or animal consumption, veterinary use, clinical diagnostics, food additives, cosmetics, or household applications.
To the maximum extent permitted by applicable law, the cumulative liability of Axiom Analytics, its officers, employees, and third-party laboratory partners to the client or any third party for any claims, losses, damages, or liabilities of any kind (including but not limited to direct, indirect, special, incidental, punitive, or consequential damages) shall be strictly limited to, and shall not exceed, the exact dollar amount paid by the client to Axiom Analytics for the specific individual analytical test run from which the liability arose.